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ABSTRACT
A previously healthy 31-year-old female presenting with 
dyspnea, iron deficiency anemia, pancytopenia, splenomegaly, 
and abnormal coagulation tests was admitted to the hospital. 
Hematology consultation additionally revealed that 71% of cells 
were indicative of  acute promyelocytic leukemia (APL) and the 
patient tested positive for a t(15;17) translocation, confirming APL. 
All-trans retinoic acid (ATRA) therapy was initiated immediately, 
but the patient exhibited severe dyspnea. This subsequently 
resulted in circulatory and respiratory arrest, followed by death. 
Just after death, fluorescein-labelled proaerolysin (FLAER) 
revealed a paroxysmal nocturnal hemoglobinuria (PNH) monocyte 
clone of 82%, confirming the diagnosis of PNH. Leukemia can 
be derived from non-PNH clones in PNH patients. Catastrophic 
thromboembolic events that could not be controlled with aggressive 
anticoagulation in a profoundly thrombocytopenic patient without 
overt  disseminated intravascular coagulation (DIC) may suggest 
co-existent PNH. 
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ÖZ
Bilinen bir hastalığı olmayan ve dispne, demir eksikliği anemisi, 
pansitopeni, splenomegali ve anormal koagülasyon testleri ile 
başvuran 31 yaşında kadın hasta hastaneye yatırıldı. Hematoloji 
değerlendirmede hücrelerin %71’inin akut promyelositik 
lösemi (APL) ile uymlu olduğu saptandı ve hastanın t(15;17) 
translokasyonu pozitif gelerek APL doğrulandı. All-trans retinoik 
asit (ATRA) tedavisi hemen başlandı ancak hastada ağır dispne 
bulguları gelişti. Bu durum dolaşımsal ve kardiyak arreste yol 
açtı ve ölümle sonuçlandı. Hastanın ölümünden sonra sonuçlanan 
FLAER tetkikinde paroksismal nokturnal hemoglobinüri tanısını 
doğrulayan 82% monosit klonu saptandı. Nokturnal hemoglobinüri 
hastalarında nokturnal hemoglobinüri dışı klonlardan lösemi 
gelişebilmektedir. Aşikar yaygın damar içi pıhtılaşması bulguları 
olmayan ağır trombositopenik bir hastada agresif antikoagülasyonla 
kontrol edilemeyen katastrofik tromboembolik olaylar eşlik eden 
nokturnal hemoglobinüriye işaret edebilir. 
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Introduction
Paroxysmal nocturnal hemoglobinuria (PNH) arises as 
a result of nonmalignant clonal expansion of one or more 
hematopoietic stem cells that have acquired a somatic 
mutation of the X chromosome gene PIGA [1]. Almost 
5-15% of patients with PNH experience malignant 
transformation. Transformation results with acute myeloid 
leukemia  in most cases and acute lymphoblastic leukemia 
being lesser [2].
Here, we report a case of acute promyelocytic leukemia 
(APL) evolving from paroxysmal nocturnal hemoglobinuria 
(PNH). This is the second report of such co-incidence. 
Immunophenotyping by flow cytometry was used to 
diagnose APL. Fluorochrome-conjugated (Alexa 488) 
fluorescein-labelled proaerolysin (FLAER) based flow 
cytometry was used to identify PNH clones. 
Case Report
A previously healthy 31-year-old female presenting with 
dyspnea, pancytopenia, splenomegaly, and abnormal 
coagulation tests was admitted to the hospital for further 
testing. Her pro-brain natriuretic peptide (proBNP) levels 
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were high (1513 pg/mL), her heart exhibited large right 
chambers, suggesting pulmonary hypertension, and 
occlusion of the lobar branches of the bilateral pulmonary 
arteries was observed, indicating pulmonary embolisms. 
Cardiological examination revealed orthopnea, bilateral 
3+pretibial edema, and raised jugular pressure. Hematology 
consultation detected no overt disseminated intravascular 
coagulation (DIC) (DIC score of 4 [<5]) [3], 5.8 % 
reticulocytes, and elevated lactate dehydrogenase of 888 
U/L (122-240 U/L). However, it was revealed that 71% of 
cells were indicative of APL (CD13+, CD33+, CD117+, 
MPO+, HLADR-) and the patient tested positive for a 
t(15;17) translocation, confirming APL (Fig. 1). All-trans 
retinoic acid (ATRA) therapy was initiated immediately, 
but  the next morning, the patient exhibited severe dyspnea. 
Her electrocardiogram (ECG) showed a large S wave in 
lead I, a Q wave in lead III, and an inverted T wave in lead 
III indicating acute right heart strain (S1Q3T3 pattern) and 
arterial blood gas analysis revealed hypoxia and hypocapnia. 
This subsequently resulted in circulatory and respiratory 
arrest followed by death, despite 45 min of cardiopulmonary 
resuscitation. Cause of death was recorded as probable 
thrombotic DIC secondary to APL, based on the specific 
ECG pattern consistent with massive pulmonary embolism 
and the arterial blood gas analysis. Just after death, FLAER 
revealed a PNH monocyte clone of 82%, confirming the 
diagnosis of PNH (Fig. 2)
Fig. 1. Bone marrow aspiration
Fig. 2. FLAER revealed a PNH monocyte clone of 82%
Discussion
PNH is a rare disorder with a minimum prevalence estimated 
to 1-1.5 cases per million [4]. Incidence of APL is unknown; it 
is also a relatively rare hematologic malignancy. The number 
of newly diagnosed cases per year in the United States is 
estimated to be 600 to 800 [5,6]. Leukemia can be derived 
from the clones other than PNH clone in PNH patients [7]. 
We could not demonstrate that the APL blasts evolved from 
PNH clone in our patient, since the diagnosis was made after 
her death. However, catastrophic thromboembolic event that 
could not be controlled with aggressive anticoagulation in 
a profoundly thrombocytopenic patient without overt DIC 
may be suggested as a result of co-existent PNH. In case 
of atypical thromboembolic events during the course of 
acute leukemia, probability of underlying PNH should be 
considered.
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